Sign Up | Log In | What is SocialPicks?

Stock symbol 601899 not yet supported on Stock Buzz.

Citrix Systems Inc (CTXS) Trade Now » Rate CTXS - Discuss CTXS - Add to Watch List

Sector: Technology > Industry: Software & Programming

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

72.0%

Top:

0.0%

Rate CTXS:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

CTXS Analysis & Videos »

... View All >

CTXS: Bull or Bear?

Citrix Systems: Steady uptrend CTXS

-0.25%
in 62 days

Filed under: Stocks to Buy

Server/deskstop virtualization software solutions designer Citrix Systems (NASDAQ: CTXS) continues to advance, as expected, which is why I'm Reiterating my Buy rating for the company, first recommended on June 16, 2009 at a price of $33.09.

In June, the argument was made that U.S. information technology spending would not decline by the projected 5-7% in FY2009, and that institutional investors would also look past CTXS's flatish FY2009 revenue to a near 10% gain in FY2010, and that's pretty much what has transpired. Shares have risen about 19% since the June Buy r...

Continue reading »

By Joseph Lazzaro (+1.82% risk: moderate) 10/07/09

Comment

Citrix Reports Second Quarter Financial Results CTXS

62%

+13.75%
in 138 days

Wednesday, July 22, 2009 4:05:09 PM ET

--GAAP Diluted Earnings Per Share of $0.23

--Non-GAAP Diluted Earnings Per Share of $0.39

Citrix Systems, Inc. ( CTXS ) today reported financial results for the second quarter of fiscal 2009 ended June 30, 2009.

FINANCIAL RESULTS

In the second quarter of fiscal 2009, Citrix achieved revenue of $393 million, compared to $392 million in the second quarter of fiscal 2008.

<> GA...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 07/23/09

Comment

Citrix Systems: Buy on a pull-back CTXS

+19.58%
in 113 days
(closed on 10/07/09)

Filed under: Stocks to Buy

Has the recent share price surge in virtualization and remote access software developer Citrix Systems (NASDAQ: CTXS) been excessive? Indeed it has, but that does not blot-out the Buy on a pull-back thesis, for moderate-risk investors. Here's why:

In general, analysts see 8-12% revenue growth for Citrix in FY2009, aided by gains in license updates and services, and by firming results in new product and software purchases.

Continue reading Citrix Systems: Buy on a pull-back

<>Citrix Systems: Buy on a pull-back originally appeared on BloggingStocks on Tue, 16 Jun 2009 1...

Continue reading »

By Joseph Lazzaro (+1.82% risk: moderate) 06/16/09

Comment

... View All >

People Bullish on CTXS

Joseph Lazzaro

Tracked Blogger

43%

2 mos ago

Marian Filo

Principal

62%

4 mos ago

oliver2227

Analyst

43%

about 1 year ago

richbull

Associate

38%

about 1 year ago

dsnyc

Analyst

52%

about 1 year ago

People Bearish on CTXS

rahimulghani

Analyst

N/A

over 2 years ago

duocvu

Sr. Analyst

67%

over 2 years ago

knannith

Sr. Analyst

8 %

over 2 years ago

Juergen Loeffelsender

Analyst

N/A

over 3 years ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+68.27%	211
3	stockmarketfunding.com	17.66	+25.61%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.42%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
POT	Potash Corp. of Saskatchewan Inc.
BIDU	Baiducom Inc ADS
FNM	Fannie Mae
GOOG	Google Inc
SIRI	Sirius Satellite Radio Inc
JPM	JPMorgan Chase & Co

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

StreetInsider.com on CTXS

Goldman Adds CVLT, JNPR and RAX to Conviction Buy List

Form 4 CITRIX SYSTEMS INC For: Dec 01 Filed by: PAYNE JOHN GORDON

Form 4 CITRIX SYSTEMS INC For: Dec 01 Filed by: FRIEDMAN DAVID R

Citrix Online Webinar: Surviving the Windows 7 Switch

Mark Templeton Speaks Before South Florida Technology Alliance

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Citrix Systems Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.